BACKGROUND: The issue of whether an involved but functioning recurrent laryngeal nerve (RLN) should be shaved or resected in locally advanced papillary thyroid carcinoma (PTC) remains controversial. Our study aimed to compare the early and late outcomes between those who underwent shaving and those who underwent resection and also to identify independent prognostic factors in this subset of patients. METHODS: Of the 77 patients with 1 RLN involved by PTC, 39 (50.6%) underwent RLN preservation (group I) while 38 (49.4%) underwent RLN resection (group II). Early and late vocal cord function (as assessed by flexible laryngoscopy) and disease status were compared between the 2 groups. A multivariate Cox proportional hazards model was carried out to identify independent factors. RESULTS: Baseline characteristics were comparable between the 2 groups. Although temporary vocal cord palsy rate was similar between the 2 groups (p=0.532), 5 patients in group II (13.2%) suffered temporary bilateral vocal cord palsies with 1 requiring a tracheostomy lasting for 1 month. After a median follow-up of 113.8 months, 1 patient from each group developed new onset vocal cord palsy. Presence of distant metastases (hazard ratio [HR]=5.892, 95% CI=1.971-17.604, p=0.001) and incomplete surgical resection in non-RLN concomitant sites (HR=2.491, 95% CI=1.181-5.476, p=0.024) were the 2 independent predictors for a poor cancer-specific survival. CONCLUSIONS: Our data suggested that shaving could preserve the normal functionality in most of the involved RLNs (>90%) in the short to medium term. In the presence of distant metastases or incomplete resection in other non-RLN concomitant sites, the argument for shaving over resection appears even stronger.
BACKGROUND: The issue of whether an involved but functioning recurrent laryngeal nerve (RLN) should be shaved or resected in locally advanced papillary thyroid carcinoma (PTC) remains controversial. Our study aimed to compare the early and late outcomes between those who underwent shaving and those who underwent resection and also to identify independent prognostic factors in this subset of patients. METHODS: Of the 77 patients with 1 RLN involved by PTC, 39 (50.6%) underwent RLN preservation (group I) while 38 (49.4%) underwent RLN resection (group II). Early and late vocal cord function (as assessed by flexible laryngoscopy) and disease status were compared between the 2 groups. A multivariate Cox proportional hazards model was carried out to identify independent factors. RESULTS: Baseline characteristics were comparable between the 2 groups. Although temporary vocal cord palsy rate was similar between the 2 groups (p=0.532), 5 patients in group II (13.2%) suffered temporary bilateral vocal cord palsies with 1 requiring a tracheostomy lasting for 1 month. After a median follow-up of 113.8 months, 1 patient from each group developed new onset vocal cord palsy. Presence of distant metastases (hazard ratio [HR]=5.892, 95% CI=1.971-17.604, p=0.001) and incomplete surgical resection in non-RLN concomitant sites (HR=2.491, 95% CI=1.181-5.476, p=0.024) were the 2 independent predictors for a poor cancer-specific survival. CONCLUSIONS: Our data suggested that shaving could preserve the normal functionality in most of the involved RLNs (>90%) in the short to medium term. In the presence of distant metastases or incomplete resection in other non-RLN concomitant sites, the argument for shaving over resection appears even stronger.
Authors: Hyoung Shin Lee; Sung Won Kim; Taejung Park; Gi Yun Nam; Jong Chul Hong; Kang Dae Lee Journal: World J Surg Date: 2015-04 Impact factor: 3.352
Authors: Brian Hung-Hin Lang; Kevin Ka-Wan Chu; Raymond King-Yin Tsang; Kai Pun Wong; Birgitta Yee-Hang Wong Journal: World J Surg Date: 2014-02 Impact factor: 3.352
Authors: Shanshan Wang; Juekun Wu; Jianwei Ren; Alexander C Vlantis; Ming-Yue Li; Shirley Y W Liu; Enders K W Ng; Amy B W Chan; Ding-Cun Luo; Zhimin Liu; Wei Guo; Lingbin Xue; Siu Kwan Ng; C Andrew van Hasselt; Michael C F Tong; George G Chen Journal: Mol Ther Date: 2018-06-21 Impact factor: 11.454
Authors: Jan Boucek; Michal Zabrodsky; Martin Kuchar; Ondrej Fanta; Jiri Skrivan; Jan Betka Journal: Biomed Res Int Date: 2014-05-14 Impact factor: 3.411
Authors: Antonio Mario Bulfamante; Eleonora Lori; Maria Irene Bellini; Elisa Bolis; Paolo Lozza; Luca Castellani; Alberto Maria Saibene; Carlotta Pipolo; Emanuela Fuccillo; Cecilia Rosso; Giovanni Felisati; Loredana De Pasquale Journal: Front Oncol Date: 2022-07-07 Impact factor: 5.738